Key presentations at the American Society of Breast Surgeons conference in 2026 emphasized the significance of tracking body composition, Bioimpedance Spectroscopy (BIS), and monitoring for lymphedema in breast cancer treatment. Held in Carlsbad, Calif., the event featured critical research findings on these topics. One of the prominent companies showcasing their advancements was ImpediMed, renowned for its innovative medical solutions for monitoring and addressing fluid levels and body composition. The conference highlighted the growing importance of incorporating such technologies in breast cancer care.
